Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Revenue

In the fiscal year ending March 31, 2026, Mankind Pharma had annual revenue of 142.78B INR with 16.96% growth. Mankind Pharma had revenue of 34.43B in the quarter ending March 31, 2026, with 11.81% growth.

• Revenue: 142.78B
• Revenue Growth: +16.96%
• P/S Ratio: 6.71
• Revenue / Employee: 7.28M
• Employees: 19,620
• Market Cap: 957.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	142.78B	20.70B	16.96%
Mar 31, 2025	122.07B	19.47B	18.98%
Mar 31, 2024	102.60B	15.11B	17.27%
Mar 31, 2023	87.49B	9.68B	12.44%
Mar 31, 2022	77.82B	15.67B	25.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error